IQVIA Holdings Inc. (NYSE: IQV), a global provider of advanced analytics solutions and clinical research services to the life sciences industry, reported financial results for the third quarter of 2023.
- Revenues came in at $3.74 billion in the September quarter, which is up 4.9% from the prior-year quarter
- Third-quarter net Income, on a reported basis, increased 7.1% annually to $303 million; EPS rose 9.4% to $1.63
- Adjusted earnings per share, excluding special items, edged up 0.4% year-over-year to $2.49 per share
- Adjusted EBITDA was $888 million during the three-month period, up 9.1% year-over-year
- R&D Solutions quarterly bookings were $2.6 billion in Q3, representing a book-to-bill ratio of 1.24x
- There was an R&D solution contracted backlog of $28.8 billion, which is up 12% year-over-year
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Infographic: How Constellation Brands (STZ) performed in Q3 2026
Constellation Brands, Inc. (NYSE: STZ) reported net sales of $2.22 billion for the third quarter of 2026, down 10% year-over-year. Organic net sales were down 2%. Net income attributable to
BLK Q4 Preview: BlackRock appears poised for another earnings beat
BlackRock, Inc. (NYSE: BLK), the largest asset management company, is set to publish its fourth-quarter 2025 results next week. The update is expected to shed light on how the firm’s
A look at Best Buy’s (BBY) progress on its growth strategy
Shares of Best Buy Co., Inc. (NYSE: BBY) fell over 3% on Wednesday. The stock has dropped 17% over the past 12 months. The consumer electronics retailer delivered sales and
